Management of trigeminal autonomic cephalgias and hemicrania continua.
The trigeminal autonomic cephalgias (TACs) are a group of primary headache disorders characterised by unilateral trigeminal distribution pain that occurs in association with ipsilateral cranial autonomic features. This group of headache disorders includes cluster headache, paroxysmal hemicrania and short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT syndrome). Although hemicrania continua has previously been classified amongst the TACs, its nosological status remains unclear. Despite their similarities, these disorders differ in their clinical manifestations and response to therapy, thus underpinning the importance of recognising them. We have outlined the clinical manifestations, differential diagnoses, diagnostic workup and the treatment options for each of these syndromes.
Matharu
Manjit S
MS
Headache Group, Institute of Neurology, The National Hospital for Neurology and Neurosurgery, London, UK.
Boes
Christopher J
CJ
Goadsby
Peter J
PJ
D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use; D000779:Anesthetics, Local / Q000494:pharmacology / Q000627:therapeutic use; D004334:Drug Administration Schedule; D004876:Ergot Alkaloids / Q000494:pharmacology / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D023303:Oxazolidinones / Q000494:pharmacology / Q000627:therapeutic use; D010100:Oxygen / Q000494:pharmacology; D018170:Sumatriptan / Q000494:pharmacology / Q000627:therapeutic use; D014277:Trigeminal Neuralgia / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D014363:Tryptamines; D014653:Vascular Headaches / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology
D000700:Analgesics; D000779:Anesthetics, Local; D004876:Ergot Alkaloids; D023303:Oxazolidinones; D014363:Tryptamines; C089750:zolmitriptan; D018170:Sumatriptan; D010100:Oxygen